Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Data for Better Patient Care: As the RISE Registry Expands, So Do Its Ambitions

Thomas R. Collins  |  Issue: March 2020  |  February 25, 2020

“Doctors really like the tool, because it provides a structure for communication in our RA encounters,” she said.

Another project looked at hydroxychloroquine prescribing patterns to see how many patients are prescribed doses generally considered too high, pointing to a need for improved care. “I think that is really the power of RISE—that we can go from data to a quality measurement strategy that’s actually meaningful for us as rheumatologists,” Dr. Yazdany said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Another project—GRASP or Genome Research in African American Scleroderma Patients—is attempting to use the RISE network to find potential patients to boost enrollment for this important National Institutes of Health-funded study.

“If this pilot [study] is successful, there will be more opportunities like this to use the power of RISE to conduct research that can advance our field,” Dr. Yazdany said.

Gabby Schmajuk, MD, MS

Gabby Schmajuk, MD, MS, who leads the RISE Data Analytic Center at the University of California, San Francisco (UCSF), said RISE data are uploaded from the practice to the registry each night, with data validation to ensure elements are in the correct fields. Then, the technology vendor does more quality assurance, followed by even more quality review and data cleaning at the data analytic center level. These centers are at UCSF, the University of Alabama, Birmingham, and Duke University, Durham, N.C.

Recently, researchers at UCSF used RISE data to assess prescription patterns among sarcoidosis patients, finding 50% of patients were on a steroid, with 15% on steroid monotherapy and another 15% on prolonged, high-dose steroids.1 Dr. Schmajuk said this indicates the need for disease-modifying agents so patients have choices other than glucocorticoids.

Another RISE project, which is ongoing, involves loading RA clinical data into a deep-learning model to predict flare at a patient’s next visit. Model runs using UCSF data have produced promising results.2

How to Access RISE

Katherine Liao, MD, MPH, chair of the ACR’s Research and Publications Subcommittee to the Research Committee, described a few paths to access to RISE data for research. When investigators want data for publication purposes, they must complete a request form that is reviewed administratively. Next, there’s a full subcommittee review, followed by a notice of approval or rejection. If approved, the project is assigned to a data analytic center.

Katherine Liao, MD, MPH

For requests that are not for publication purposes, such as summary reports, a partial subcommittee review is conducted.

Page: 1 2 3 | Single Page
Share: 

Filed under:Meeting Reports Tagged with:2019 ACR/ARP Annual MeetingRISE

Related Articles

    Using RISE Data in Research

    October 17, 2019

    The ACR’s RISE registry offers answers on real-world experience to researchers.

    The RISE Registry Delivers Practice-Based Evidence to Rheumatologists

    April 15, 2019

    The advent of quality-based healthcare, such as the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), requires rheumatology professionals to demonstrate their practice is based on interventions supported by the best available evidence and that their practice, in turn, provides quality care. These requirements have increased the need for methods to measure and quantify…

    The RISE Registry: A Powerful Collaboration Tool for Clinicians & Researchers

    March 21, 2019

    Practice-based evidence, like that in the RISE registry, can be used to describe trends in patient care, look at comparative effectiveness of interventions and much more.

    RISE Data Use to Be Highlighted at 2017 ACR/ARHP Annual Meeting

    September 20, 2017

    This year’s ACR/ARHP Annual Meeting, which takes place Nov. 3–8 in San Diego, features several opportunities to learn more about the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry, and the data and tools it offers rheumatologists. For the first time, RISE data will be presented at the Annual Meeting by rheumatologists outside of the ACR’s…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences